2 results
Approved WMOCompleted
The primary objective of this study is to evaluate the safety and tolerability of trastuzumab emtansine.
Approved WMOPending
The primary objective of this study is to evaluate the efficacy of SCH 503034800 mg TID PO in combination with PegIntron 1.5 *g/kg QW SC plus ribavirin (800 - 1400 mg/day) in previously untreated adult chronic hepatitis C (CHC) subjects infected…